Compare PPSI & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PPSI | LEXX |
|---|---|---|
| Founded | 2008 | 2004 |
| Country | United States | Canada |
| Employees | N/A | 7 |
| Industry | Electrical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.3M | 16.2M |
| IPO Year | 2008 | N/A |
| Metric | PPSI | LEXX |
|---|---|---|
| Price | $3.14 | $0.72 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $12.00 | $1.50 |
| AVG Volume (30 Days) | 70.4K | ★ 133.9K |
| Earning Date | 04-14-2026 | 04-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1626.32 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $22,879,000.00 | N/A |
| Revenue This Year | $26.84 | N/A |
| Revenue Next Year | $10.26 | $601.47 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.26 | $0.46 |
| 52 Week High | $5.70 | $1.90 |
| Indicator | PPSI | LEXX |
|---|---|---|
| Relative Strength Index (RSI) | 33.12 | 49.84 |
| Support Level | $2.85 | $0.62 |
| Resistance Level | $4.05 | $0.87 |
| Average True Range (ATR) | 0.23 | 0.08 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 7.14 | 32.68 |
Pioneer Power Solutions Inc designs, manufactures, integrates, services, and sells distributed energy resources, on-site and mobile power generation equipment, and a platform of mobile electric vehicle (EV) charging solutions.. Its principal products and services include custom-engineered electrical transformers, switchgear and engine-generator sets and controls, complemented by a national field-service network to maintain and repair power generation assets.
Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.